Le Lézard
Classified in: Health, Business
Subjects: FNC, VEN, TRI, SBS

Savage Medical Exits Stealth With Over $3 Million to Enable Minimally Invasive Colorectal Tumor Removal


SAN FRANCISCO, Nov. 28, 2023 /PRNewswire/ -- Savage Medical, Inc. ("SavageMed", "Company", "We", or "Us"), a San Francisco Bay Area-based, clinical-stage medical technology company enabling minimally invasive colorectal tumor removal, today announced a launch out of stealth with over $3 million in total funding, including oversubscribed financing from leading early-stage medical technology investors including Synergy Ventures, Life Science Angels and AlwaysraiseVC. Capital raised contributes to SavageMed's ongoing clinical trial of its groundbreaking ColoSealtm System. SavageMed's ColoSealtm has been successfully tested in human clinical trials with positive results.

"Today, surgery for colorectal tumors frequently requires up to 3 surgical procedures to remove the tumor and avoid the side effects of the tumor removal, including the dreaded need for a temporary ostomy bag," said Ankit Sarin, M.D., M.H.A., Chief, Division of Colorectal Surgery, Vice Chair of Robotics & New Technologies, Department of Surgery, UC Davis Health. "ColoSeal allows a one-time, minimally invasive procedure after the tumor removal that potentially eliminates the need for the additional surgical procedures and avoids need for an ostomy."

"Every year, there are 1.9 million people diagnosed with colorectal cancer. 35% of these patients have localized tumors which require surgery to remove," said Kenton Fong, M.D., Chief Executive Officer of Savage Medical, Inc. "We are thrilled to close this latest financing to continue advancing the ColoSeal System through clinical trials. Our vision is to replace the multiple surgical procedures and complications that hundreds of thousands of colorectal patients endure each year with a minimally invasive solution."

About Savage Medical, Inc.
Savage Medical, Inc ("SavageMed") is a clinical-stage, San Francisco Bay Area-based medical technology company founded by former Spiracur (now 3M Science) executives developing the ColoSealtm System to enable minimally invasive colorectal tumor removal. SavageMed has been selected as a UCSF Rosenman Innovator company, a MedTech Innovator company, and has been the recipient of both U.S. National Cancer Institute (NCI) and U.S. National Science Foundation (NSF) Small Business Innovation Research (SBIR) grants. Existing investors include Synergy Ventures, Life Science Angels, and AlwaysraiseVC. To learn more, visit www.savagemed.com.

Contacts:
Kenton Fong, Chief Executive Officer
[email protected] 
510-206-0549

SOURCE Savage Medical, Inc.


These press releases may also interest you

at 10:29
Thelansis Knowledge Partners is a specialized business research and consulting company that provides pharmaceutical and biopharmaceutical companies with data-driven research, insights, and decision-making support throughout the product life cycle....

at 10:26
Thelansis Knowledge Partners is a specialized business research and consulting company that provides pharmaceutical and biopharmaceutical companies with data-driven research, insights, and decision-making support throughout the product life cycle....

at 10:25
Atrium Health's Division of Abdominal Transplant, Carolinas Medical Center (DAT Atrium), LifeShare Carolinas, one of nation's leading Organ...

at 10:20
Mistreatment of older adults can have serious health and psychosocial consequences, including premature mortality, poor physical and mental health, diminished quality of life, and increased rates of emergency services use, hospitalization, and...

at 10:20
Recognizing athletic achievements is not an uncommon occurrence. From the Super Bowl to the World Cup, these pinnacles of athletic success are recognized the world over and the talented players that perform at these levels are celebrated for their...

at 10:17
Designs for Health, the expert-recommended and preferred brand for high-quality, professional strength, research-backed supplements, today announced the expansion of its cardiovascular health portfolio with the launch of Vascanox HP® and Nitric Oxide...



News published on and distributed by: